InvestSMART

Anteris Technologies Ltd (ASX: AVR) - Announcements

Current share price for AVR : $11.640 0.36 (3%)+

ASX company news and announcements for Anteris Technologies Ltd (AVR) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Anteris Technologies Ltd (AVR) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Anteris Technologies Ltd (AVR), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Anteris Technologies Ltd (AVR)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$1,135 Notice of Annual General Meeting Withdrawal of Resolutions 29 May 2023 8:21AM $23.670 $11.640 fallen by 50.82%
$1,135 Ceasing to be a substantial holder from MUFG 22 May 2023 1:26PM $23.670 $11.640 fallen by 50.82%
$1,135 FIH Results Presented at EuroPCR & Simultaneous Publication 22 May 2023 10:00AM $23.000 $11.640 fallen by 49.39%
$1,135 Ceasing to be a substantial holder from MS 19 May 2023 6:16PM $23.000 $11.640 fallen by 49.39%
$1,135 Becoming a substantial holder from MUFG 19 May 2023 4:54PM $23.000 $11.640 fallen by 49.39%
$1,135 Becoming a substantial holder from MS 19 May 2023 8:15AM $22.700 $11.640 fallen by 48.72%
$1,135 Ceasing to be a substantial holder from MUFG 18 May 2023 5:16PM $22.700 $11.640 fallen by 48.72%
$1,135 Ceasing to be a substantial holder from MS 18 May 2023 8:13AM $22.400 $11.640 fallen by 48.04%
$1,135 Additional Patent for Heart Valve Replacement Technology 17 May 2023 8:49AM $21.510 $11.640 fallen by 45.89%
$1,135 Becoming a substantial holder from MUFG 12 May 2023 4:53PM $22.460 $11.640 fallen by 48.17%
$1,135 Becoming a substantial holder from MS 12 May 2023 11:54AM $21.950 $11.640 fallen by 46.97%
$1,135 Ceasing to be a substantial holder from MUFG 11 May 2023 6:41PM $22.830 $11.640 fallen by 49.01%
$1,135 Ceasing to be a substantial holder from MS 11 May 2023 8:15AM $22.850 $11.640 fallen by 49.06%
$1,135 Cleansing Notice 5 May 2023 9:55AM $22.000 $11.640 fallen by 47.09%
$1,135 Application for quotation of securities - AVR 5 May 2023 9:53AM $22.000 $11.640 fallen by 47.09%
$1,135 Notice of Annual General Meeting/Proxy Form 28 Apr 2023 2:51PM $22.150 $11.640 fallen by 47.45%
$1,135 Quarterly Activities/Appendix 4C Cash Flow Report 24 Apr 2023 9:32AM $22.950 $11.640 fallen by 49.28%
$1,135 Application for quotation of securities - AVR 20 Apr 2023 4:49PM $23.980 $11.640 fallen by 51.46%
$1,135 Cleansing Notice 20 Apr 2023 2:40PM $23.600 $11.640 fallen by 50.68%
$1,135 Application for quotation of securities - AVR 20 Apr 2023 2:37PM $23.960 $11.640 fallen by 51.42%
$1,135 Agreement to Develop New Heart Valve Repair Device 19 Apr 2023 9:20AM $23.700 $11.640 fallen by 50.89%
$1,135 Corporate Governance Statement and Appendix 4G 14 Apr 2023 5:02PM $25.200 $11.640 fallen by 53.81%
$1,135 Annual Report to shareholders 14 Apr 2023 5:01PM $25.200 $11.640 fallen by 53.81%
$1,135 Patent for Transcatheter Heart Valve Replacement Technology 12 Apr 2023 9:08AM $22.500 $11.640 fallen by 48.27%
$1,135 Becoming a substantial holder from MUFG 12 Apr 2023 8:15AM $22.500 $11.640 fallen by 48.27%

376 - 400 of 712 results

Page 16 of 29

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.